Work

337 (PB325): Poly(ADP-Ribose) Polymerase (PARP) inhibition in metastatic breast cancer: comparison of therapeutic outcomes between patients with BRCA1/2 mutations and other alterations

Year: 2024

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2024.114850

Authors: N. Coleman, N.Y.L. Ngoi, D. Nguyen, B. Nelson, E. Dumbrava, S. Fu, D.S. Hong, D. Karp, A. Naing, S.A. Piha-Paul, J. Rodon, A. Tsimberidou-, B. Lim, P. Pohlman, F. Meric-Bernstam, J.K. Litton, B. Arun, T.A. Yap

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403762885

FWCI:

Cites:

Cited by:

Related to: 10